| 1 |
31949084 | No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes. | 2020 Mar |
1 |
| 2 |
27426125 | Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome. | 2016 |
1 |
| 3 |
27780736 | Add-on therapy with anagliptin in Japanese patients with type-2 diabetes mellitus treated with metformin and miglitol can maintain higher concentrations of biologically active GLP-1/total GIP and a lower concentration of leptin. | 2016 Dec |
1 |
| 4 |
24186866 | Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and "isoglycemic" intravenous glucose. | 2014 Feb |
1 |
| 5 |
24647737 | Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metformin. | 2014 Aug |
1 |
| 6 |
24321717 | Effects of aerobic exercise with or without metformin on plasma incretins in type 2 diabetes. | 2013 Dec |
2 |
| 7 |
20868233 | Acute and long-term effects of metformin on the function and insulin secretory responsiveness of clonal β-cells. | 2010 Dec |
1 |
| 8 |
19375579 | Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin. | 2009 May |
3 |